Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
FEBS Letters|October 12, 2007
RAC3 down-regulation sensitizes human chronic myeloid leukemia cells to TRAIL-induced apoptosisGeorgina P Colo, Roberto R Rosato, Steven Grant, et al.
Antimicrobial Agents and Chemotherapy|July 16, 2014
Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistanceRegina Fernandez, Liliana I Paz, Roberto R Rosato, et al.
Msphere|February 15, 2019
VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus InfectionAgustina Taglialegna, Maria C Varela, Roberto R Rosato, et al.
Molecular Therapy. Nucleic Acids|August 6, 2014
Oligonucleotide aptamers: new tools for targeted cancer therapyHongguang Sun, Xun Zhu, Patrick Y Lu, et al.
Plos One|May 3, 2013
Targeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strainsKonrad B Plata, Sarah Riosa, Christopher R Singh, et al.
Plos One|June 17, 2014
TCA cycle-mediated generation of ROS is a key mediator for HeR-MRSA survival under β-lactam antibiotic exposureRoberto R Rosato, Regina Fernandez, Liliana I Paz, et al.
Molecular Cancer Therapeutics|December 7, 2002
The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cellsRoberto R Rosato, Jorge A Almenara, Leanne Cartee, et al.
Plos One|August 14, 2013
Exposure of clinical MRSA heterogeneous strains to β-lactams redirects metabolism to optimize energy production through the TCA cycleMignon A Keaton, Roberto R Rosato, Konrad B Plata, et al.
International Journal of Oncology|May 5, 2005
Modulation of sensitivity to doxorubicin by the histone deacetylase inhibitor sodium butyrate in breast cancer cellsMonette Louis, Roberto R Rosato, Eric Battaglia, et al.
Breast Cancer Research : BCR|November 5, 2020
A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrationsTejaswini P Reddy, Roberto R Rosato, Xiaoxian Li, et al.
Pageof 5